Navigation Links
Rational Design of Modified Release Dosage Forms: From Pharmacokinetic Targets Through Technology Selection, new life science webinar hosted by Xtalks
Date:8/27/2013

Toronto, Canada (PRWEB) August 27, 2013

Designing dosage forms that allow for more effective drug delivery and release is critical for success in both the clinic and marketplace.

During this webinar, presenters will discuss a wide array of scalable dosage form technologies available. From tablet and multiparticulate forms to continuous and pulsatile release, esteemed scientists from Bend Research will discuss strategies in dosage design. As well, this webinar will pay particular focus on matching technology strengths with API properties and how to bring the array of choices together through biological modeling.

A Q&A with the presenters, Chris Craig, Director of Dosage Form Product Development, Bend Research, Inc., and Brett Caldwell, Ph.D., Director of Formulation Science, Bend Research, Inc., will follow the main presentation.

For more information about this event or to register, visit: http://www.xtalks.com/rational-design-of-modified-release-dosage-forms.ashx
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/8/prweb11060500.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Sequenom Announces 2011 Operational Highlights and Early 2012 Outlook
2. Transportation and Energy Customers Look to Wharfedale’s SAP® Solutions with an Eye toward Cost Savings and Improved Operational Efficiencies
3. Bringing New Cell Therapies to Market Requires Top-Notch Logistics and Operational Efficiency
4. Regeneron Pharmaceuticals’ Industrial Operations & Product Supply Site Receives International Recognition for Operational Excellence
5. PharmAthene Reports Year-End 2012 Financial And Operational Results
6. Vet-Stem, Inc. Founder, Robert Harman, DVM, Invited as Inspirational Speaker for the 6th Annual After the Finish Line Charity Dinner
7. Synthetic Biologics Reports Second Quarter 2013 Financial Results and Operational Update
8. Vote to Help Award a $21,000 AbbVie CF Scholarship to Two Inspirational Students with Cystic Fibrosis Pursuing their Goals of Higher Education
9. In new quantum-dot LED design, researchers turn troublesome molecules to their advantage
10. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
11. Amsterdam Molecular Therapeutics Receives US Orphan Designation for Hemophilia B Gene Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... India , January 18, 2017 According to a ... (Cancer Diagnosis, Neuroscience, Cytology, Infectious Disease), & End User (Molecular Diagnostic Laboratories, Academic ... is expected to reach USD 739.9 Million by 2021 from USD 557.1 Million ... Continue Reading ... MarketsandMarkets Logo ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... Ops Executives 2017 in its continued commitment to the advancement of the clinical ... discuss current issues related to clinical trial planning and management. , As ...
(Date:1/18/2017)... ... 2017 , ... MYOLYN, which creates medical technology for people ... to the FDA, requesting clearance of the MyoCycle Home and the MyoCycle Pro ... , The submission marks a major milestone for the technology startup. MYOLYN spun ...
(Date:1/18/2017)... , ... January 18, 2017 , ... ... publishing of the latest paper by its Science Editor, Dr. Elisabeth Bik, in ... voor Medische Microbiologie). Dr. Bik joined uBiome in October 2016 from her previous ...
Breaking Biology Technology:
(Date:1/6/2017)... 2017  Privately-held CalciMedica, Inc., announced that it ... of a novel calcium release-activated calcium (CRAC) channel ... Acute pancreatitis, sudden painful inflammation of ... can be very serious.  In severe cases it can ... hospital stays, time in the ICU and substantial ...
(Date:1/4/2017)... LAS VEGAS , Jan. 4, 2017 /PRNewswire/ ... in performance biometric sensor technology, today announced the ... Benchmark™ sensor systems, the highly-accurate biometric sensor ... ® biometric technology, experience and expertise. The ... of Benchmark designed specifically for hearables, and Benchmark ...
(Date:12/20/2016)... -- The rising popularity of mobility services such ... significant interest in keyless access systems. Following the ... (BLE), biometrics and near-field communication (NFC) are poised ... technologies in the automotive industry. This evolution from ... opens the market to specialist companies such as ...
Breaking Biology News(10 mins):